nodes	percent_of_prediction	percent_of_DWPC	metapath
Suprofen—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.288	0.406	CbGbCtD
Suprofen—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.153	0.215	CbGbCtD
Suprofen—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.153	0.215	CbGbCtD
Suprofen—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.116	0.163	CbGbCtD
Suprofen—Bleeding tendency—Montelukast—chronic obstructive pulmonary disease	0.0557	0.447	CcSEcCtD
Suprofen—Haemorrhagic disorder—Montelukast—chronic obstructive pulmonary disease	0.0184	0.147	CcSEcCtD
Suprofen—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00343	0.0275	CcSEcCtD
Suprofen—Tolmetin—CXCL8—chronic obstructive pulmonary disease	0.00328	0.257	CrCbGaD
Suprofen—Stinging—Prednisolone—chronic obstructive pulmonary disease	0.00317	0.0254	CcSEcCtD
Suprofen—Tolmetin—MPO—chronic obstructive pulmonary disease	0.00255	0.2	CrCbGaD
Suprofen—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00245	0.0197	CcSEcCtD
Suprofen—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00226	0.0181	CcSEcCtD
Suprofen—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00225	0.018	CcSEcCtD
Suprofen—PTGS1—Overview of nanoparticle effects—HMOX1—chronic obstructive pulmonary disease	0.00199	0.013	CbGpPWpGaD
Suprofen—PTGS2—C-MYB transcription factor network—ELANE—chronic obstructive pulmonary disease	0.00186	0.0121	CbGpPWpGaD
Suprofen—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00185	0.012	CbGpPWpGaD
Suprofen—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00174	0.014	CcSEcCtD
Suprofen—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00174	0.014	CcSEcCtD
Suprofen—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00168	0.0109	CbGpPWpGaD
Suprofen—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00164	0.0132	CcSEcCtD
Suprofen—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00164	0.0131	CcSEcCtD
Suprofen—Ketoprofen—CXCL8—chronic obstructive pulmonary disease	0.0016	0.125	CrCbGaD
Suprofen—PTGS2—Overview of nanoparticle effects—HMOX1—chronic obstructive pulmonary disease	0.00158	0.0103	CbGpPWpGaD
Suprofen—Ibuprofen—CXCL8—chronic obstructive pulmonary disease	0.00157	0.124	CrCbGaD
Suprofen—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00157	0.0126	CcSEcCtD
Suprofen—PTGS1—Overview of nanoparticle effects—CRP—chronic obstructive pulmonary disease	0.00156	0.0102	CbGpPWpGaD
Suprofen—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00154	0.0124	CcSEcCtD
Suprofen—UGT2B7—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00149	0.00969	CbGpPWpGaD
Suprofen—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00148	0.0119	CcSEcCtD
Suprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	0.00146	0.00953	CbGpPWpGaD
Suprofen—Pain—Formoterol—chronic obstructive pulmonary disease	0.00144	0.0116	CcSEcCtD
Suprofen—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00144	0.0116	CcSEcCtD
Suprofen—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—chronic obstructive pulmonary disease	0.00144	0.00935	CbGpPWpGaD
Suprofen—Pain—Montelukast—chronic obstructive pulmonary disease	0.00141	0.0114	CcSEcCtD
Suprofen—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00136	0.0109	CcSEcCtD
Suprofen—UGT2B7—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.00131	0.00849	CbGpPWpGaD
Suprofen—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.0013	0.00848	CbGpPWpGaD
Suprofen—PTGS1—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.0013	0.00843	CbGpPWpGaD
Suprofen—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00129	0.0104	CcSEcCtD
Suprofen—UGT2B7—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.00129	0.00839	CbGpPWpGaD
Suprofen—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00129	0.0103	CcSEcCtD
Suprofen—UGT2B7—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.00128	0.0083	CbGpPWpGaD
Suprofen—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00124	0.00999	CcSEcCtD
Suprofen—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00124	0.00999	CcSEcCtD
Suprofen—PTGS2—Overview of nanoparticle effects—CRP—chronic obstructive pulmonary disease	0.00124	0.00806	CbGpPWpGaD
Suprofen—CYP2C9—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00122	0.00795	CbGpPWpGaD
Suprofen—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00122	0.00978	CcSEcCtD
Suprofen—UGT1A1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00121	0.00788	CbGpPWpGaD
Suprofen—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00959	CcSEcCtD
Suprofen—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00959	CcSEcCtD
Suprofen—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00118	0.00764	CbGpPWpGaD
Suprofen—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00943	CcSEcCtD
Suprofen—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00117	0.0094	CcSEcCtD
Suprofen—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00906	CcSEcCtD
Suprofen—PTGS2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.00113	0.00733	CbGpPWpGaD
Suprofen—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00112	0.009	CcSEcCtD
Suprofen—PTGS1—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00112	0.00726	CbGpPWpGaD
Suprofen—Naproxen—CYP1A2—chronic obstructive pulmonary disease	0.00111	0.0871	CrCbGaD
Suprofen—UGT2B7—Phase II conjugation—CYP1A2—chronic obstructive pulmonary disease	0.00107	0.00698	CbGpPWpGaD
Suprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.00106	0.00692	CbGpPWpGaD
Suprofen—UGT1A1—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.00106	0.0069	CbGpPWpGaD
Suprofen—UGT1A1—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.00105	0.00682	CbGpPWpGaD
Suprofen—UGT1A1—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.00104	0.00674	CbGpPWpGaD
Suprofen—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.00103	0.00673	CbGpPWpGaD
Suprofen—PTGS2—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.00103	0.0067	CbGpPWpGaD
Suprofen—PTGS1—Overview of nanoparticle effects—CXCL8—chronic obstructive pulmonary disease	0.00101	0.0066	CbGpPWpGaD
Suprofen—PTGS2—Spinal Cord Injury—MMP12—chronic obstructive pulmonary disease	0.00101	0.00657	CbGpPWpGaD
Suprofen—PTGS2—Aryl Hydrocarbon Receptor—CYP1A2—chronic obstructive pulmonary disease	0.000948	0.00616	CbGpPWpGaD
Suprofen—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000943	0.00757	CcSEcCtD
Suprofen—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.00094	0.00755	CcSEcCtD
Suprofen—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000936	0.00751	CcSEcCtD
Suprofen—UGT2B7—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.00093	0.00605	CbGpPWpGaD
Suprofen—UGT2B7—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	0.000895	0.00582	CbGpPWpGaD
Suprofen—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000888	0.00578	CbGpPWpGaD
Suprofen—PTGS2—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000887	0.00577	CbGpPWpGaD
Suprofen—UGT1A1—Phase II conjugation—CYP1A2—chronic obstructive pulmonary disease	0.000872	0.00567	CbGpPWpGaD
Suprofen—PTGS1—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000871	0.00566	CbGpPWpGaD
Suprofen—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000854	0.00555	CbGpPWpGaD
Suprofen—UGT2B7—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000851	0.00553	CbGpPWpGaD
Suprofen—UGT2B7—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	0.000822	0.00535	CbGpPWpGaD
Suprofen—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000815	0.00654	CcSEcCtD
Suprofen—PTGS1—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000812	0.00528	CbGpPWpGaD
Suprofen—UGT2B7—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000807	0.00525	CbGpPWpGaD
Suprofen—PTGS2—Overview of nanoparticle effects—CXCL8—chronic obstructive pulmonary disease	0.000806	0.00524	CbGpPWpGaD
Suprofen—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000799	0.0052	CbGpPWpGaD
Suprofen—UGT2B7—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000791	0.00515	CbGpPWpGaD
Suprofen—PTGS1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000783	0.00509	CbGpPWpGaD
Suprofen—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000782	0.00628	CcSEcCtD
Suprofen—UGT1A1—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000756	0.00492	CbGpPWpGaD
Suprofen—UGT2B7—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000755	0.00491	CbGpPWpGaD
Suprofen—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—chronic obstructive pulmonary disease	0.000751	0.00488	CbGpPWpGaD
Suprofen—UGT2B7—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000746	0.00485	CbGpPWpGaD
Suprofen—UGT1A1—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	0.000727	0.00473	CbGpPWpGaD
Suprofen—PTGS2—C-MYB transcription factor network—MPO—chronic obstructive pulmonary disease	0.000717	0.00467	CbGpPWpGaD
Suprofen—PTGS1—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000707	0.0046	CbGpPWpGaD
Suprofen—Fenoprofen—ALB—chronic obstructive pulmonary disease	0.000704	0.0553	CrCbGaD
Suprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—chronic obstructive pulmonary disease	0.000693	0.00451	CbGpPWpGaD
Suprofen—UGT1A1—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000691	0.0045	CbGpPWpGaD
Suprofen—PTGS2—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000691	0.00449	CbGpPWpGaD
Suprofen—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000689	0.00448	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000687	0.00447	CbGpPWpGaD
Suprofen—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000685	0.0055	CcSEcCtD
Suprofen—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000674	0.00541	CcSEcCtD
Suprofen—UGT1A1—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	0.000668	0.00435	CbGpPWpGaD
Suprofen—UGT1A1—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000656	0.00426	CbGpPWpGaD
Suprofen—PTGS2—S1P1 pathway—VEGFA—chronic obstructive pulmonary disease	0.000654	0.00426	CbGpPWpGaD
Suprofen—PTGS2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000644	0.00419	CbGpPWpGaD
Suprofen—UGT1A1—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000643	0.00418	CbGpPWpGaD
Suprofen—Naproxen—ALB—chronic obstructive pulmonary disease	0.000641	0.0503	CrCbGaD
Suprofen—UGT2B7—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000628	0.00408	CbGpPWpGaD
Suprofen—UGT2B7—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000619	0.00403	CbGpPWpGaD
Suprofen—UGT1A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000614	0.00399	CbGpPWpGaD
Suprofen—UGT1A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000607	0.00394	CbGpPWpGaD
Suprofen—UGT2B7—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000597	0.00388	CbGpPWpGaD
Suprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	0.000589	0.00383	CbGpPWpGaD
Suprofen—UGT2B7—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000588	0.00383	CbGpPWpGaD
Suprofen—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000587	0.00382	CbGpPWpGaD
Suprofen—PTGS1—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.00057	0.00371	CbGpPWpGaD
Suprofen—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000569	0.0037	CbGpPWpGaD
Suprofen—PTGS2—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000561	0.00365	CbGpPWpGaD
Suprofen—UGT2B7—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000548	0.00357	CbGpPWpGaD
Suprofen—UGT2B7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000523	0.0034	CbGpPWpGaD
Suprofen—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000519	0.00338	CbGpPWpGaD
Suprofen—UGT2B7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000516	0.00336	CbGpPWpGaD
Suprofen—UGT1A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00051	0.00332	CbGpPWpGaD
Suprofen—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000507	0.0033	CbGpPWpGaD
Suprofen—UGT1A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000503	0.00327	CbGpPWpGaD
Suprofen—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000501	0.00326	CbGpPWpGaD
Suprofen—PTGS1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.0005	0.00325	CbGpPWpGaD
Suprofen—PTGS1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000494	0.00322	CbGpPWpGaD
Suprofen—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00049	0.00393	CcSEcCtD
Suprofen—UGT1A1—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000485	0.00315	CbGpPWpGaD
Suprofen—UGT2B7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000481	0.00313	CbGpPWpGaD
Suprofen—UGT1A1—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000478	0.00311	CbGpPWpGaD
Suprofen—UGT2B7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000474	0.00309	CbGpPWpGaD
Suprofen—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00047	0.00378	CcSEcCtD
Suprofen—Flurbiprofen—ALB—chronic obstructive pulmonary disease	0.000459	0.0361	CrCbGaD
Suprofen—PTGS1—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000458	0.00298	CbGpPWpGaD
Suprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	0.000458	0.00298	CbGpPWpGaD
Suprofen—UGT2B7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000456	0.00297	CbGpPWpGaD
Suprofen—PTGS2—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000453	0.00294	CbGpPWpGaD
Suprofen—UGT2B7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.00045	0.00292	CbGpPWpGaD
Suprofen—PTGS2—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	0.000449	0.00292	CbGpPWpGaD
Suprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	0.000449	0.00292	CbGpPWpGaD
Suprofen—UGT1A1—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000446	0.0029	CbGpPWpGaD
Suprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	0.000427	0.00278	CbGpPWpGaD
Suprofen—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000427	0.00277	CbGpPWpGaD
Suprofen—UGT1A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000425	0.00277	CbGpPWpGaD
Suprofen—UGT1A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000419	0.00273	CbGpPWpGaD
Suprofen—PTGS1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000416	0.0027	CbGpPWpGaD
Suprofen—Ketoprofen—ALB—chronic obstructive pulmonary disease	0.000416	0.0326	CrCbGaD
Suprofen—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000411	0.00268	CbGpPWpGaD
Suprofen—Ibuprofen—ALB—chronic obstructive pulmonary disease	0.000409	0.0321	CrCbGaD
Suprofen—UGT1A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000391	0.00254	CbGpPWpGaD
Suprofen—UGT1A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000385	0.00251	CbGpPWpGaD
Suprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—chronic obstructive pulmonary disease	0.000372	0.00242	CbGpPWpGaD
Suprofen—UGT1A1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000371	0.00241	CbGpPWpGaD
Suprofen—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000369	0.0024	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—APIP—chronic obstructive pulmonary disease	0.000367	0.00239	CbGpPWpGaD
Suprofen—UGT1A1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000365	0.00238	CbGpPWpGaD
Suprofen—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000364	0.00237	CbGpPWpGaD
Suprofen—PTGS2—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000363	0.00236	CbGpPWpGaD
Suprofen—PTGS1—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000352	0.00229	CbGpPWpGaD
Suprofen—PTGS1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000352	0.00229	CbGpPWpGaD
Suprofen—PTGS1—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000351	0.00228	CbGpPWpGaD
Suprofen—PTGS1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000347	0.00225	CbGpPWpGaD
Suprofen—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	0.000323	0.0021	CbGpPWpGaD
Suprofen—PTGS1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000319	0.00207	CbGpPWpGaD
Suprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	0.000303	0.00197	CbGpPWpGaD
Suprofen—PTGS1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000302	0.00196	CbGpPWpGaD
Suprofen—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000299	0.00194	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000298	0.00194	CbGpPWpGaD
Suprofen—PTGS2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	0.00029	0.00189	CbGpPWpGaD
Suprofen—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000286	0.00186	CbGpPWpGaD
Suprofen—PTGS2—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	0.000281	0.00183	CbGpPWpGaD
Suprofen—PTGS2—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000279	0.00182	CbGpPWpGaD
Suprofen—PTGS2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000279	0.00182	CbGpPWpGaD
Suprofen—PTGS2—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000279	0.00181	CbGpPWpGaD
Suprofen—PTGS2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	0.000276	0.0018	CbGpPWpGaD
Suprofen—PTGS2—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	0.000276	0.00179	CbGpPWpGaD
Suprofen—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000263	0.00171	CbGpPWpGaD
Suprofen—PTGS2—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	0.000262	0.0017	CbGpPWpGaD
Suprofen—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00026	0.00169	CbGpPWpGaD
Suprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—chronic obstructive pulmonary disease	0.000259	0.00168	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000243	0.00158	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000243	0.00158	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—GC—chronic obstructive pulmonary disease	0.000236	0.00154	CbGpPWpGaD
Suprofen—PTGS2—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000227	0.00147	CbGpPWpGaD
Suprofen—UGT2B7—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000223	0.00145	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00022	0.00143	CbGpPWpGaD
Suprofen—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000219	0.00142	CbGpPWpGaD
Suprofen—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000216	0.0014	CbGpPWpGaD
Suprofen—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.000207	0.00135	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000197	0.00128	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000193	0.00125	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—GC—chronic obstructive pulmonary disease	0.000192	0.00125	CbGpPWpGaD
Suprofen—PTGS2—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	0.000187	0.00122	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000185	0.0012	CbGpPWpGaD
Suprofen—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000182	0.00119	CbGpPWpGaD
Suprofen—UGT1A1—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000182	0.00118	CbGpPWpGaD
Suprofen—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.00018	0.00117	CbGpPWpGaD
Suprofen—PTGS2—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	0.000179	0.00117	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000179	0.00116	CbGpPWpGaD
Suprofen—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000173	0.00113	CbGpPWpGaD
Suprofen—PTGS2—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	0.000169	0.0011	CbGpPWpGaD
Suprofen—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000167	0.00109	CbGpPWpGaD
Suprofen—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	0.000167	0.00109	CbGpPWpGaD
Suprofen—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000165	0.00107	CbGpPWpGaD
Suprofen—PTGS2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.000165	0.00107	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000161	0.00105	CbGpPWpGaD
Suprofen—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.00016	0.00104	CbGpPWpGaD
Suprofen—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000159	0.00103	CbGpPWpGaD
Suprofen—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000157	0.00102	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	0.000157	0.00102	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000146	0.000947	CbGpPWpGaD
Suprofen—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	0.000139	0.000906	CbGpPWpGaD
Suprofen—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000138	0.000895	CbGpPWpGaD
Suprofen—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	0.000137	0.000889	CbGpPWpGaD
Suprofen—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	0.000133	0.000864	CbGpPWpGaD
Suprofen—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	0.00013	0.000846	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000129	0.00084	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000128	0.000831	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	0.000128	0.000831	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000128	0.00083	CbGpPWpGaD
Suprofen—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000127	0.000824	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	0.000124	0.000808	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000116	0.000758	CbGpPWpGaD
Suprofen—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000116	0.000754	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000116	0.000752	CbGpPWpGaD
Suprofen—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	0.000115	0.000746	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000107	0.000698	CbGpPWpGaD
Suprofen—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	0.000105	0.000683	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000105	0.000682	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000104	0.000675	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000103	0.000672	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	9.48e-05	0.000617	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	9.46e-05	0.000616	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	9.29e-05	0.000605	CbGpPWpGaD
Suprofen—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	9.21e-05	0.000599	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	9.11e-05	0.000592	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.95e-05	0.000582	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	8.85e-05	0.000576	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.83e-05	0.000574	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.72e-05	0.000567	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.55e-05	0.000556	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.46e-05	0.00055	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	8.46e-05	0.00055	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	8.39e-05	0.000546	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	8.23e-05	0.000535	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.23e-05	0.000535	CbGpPWpGaD
Suprofen—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.88e-05	0.000513	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	7.8e-05	0.000508	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.8e-05	0.000507	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	7.72e-05	0.000502	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.65e-05	0.000498	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.27e-05	0.000473	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.17e-05	0.000467	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.11e-05	0.000462	CbGpPWpGaD
Suprofen—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	6.81e-05	0.000443	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.79e-05	0.000442	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	6.71e-05	0.000437	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.68e-05	0.000435	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.34e-05	0.000412	CbGpPWpGaD
Suprofen—PTGS2—Disease—KL—chronic obstructive pulmonary disease	6.34e-05	0.000412	CbGpPWpGaD
Suprofen—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.26e-05	0.000407	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	6.13e-05	0.000398	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.1e-05	0.000397	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.93e-05	0.000386	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.85e-05	0.00038	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.64e-05	0.000367	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.45e-05	0.000354	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—ALB—chronic obstructive pulmonary disease	5.3e-05	0.000345	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.17e-05	0.000336	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—NOS3—chronic obstructive pulmonary disease	5.07e-05	0.00033	CbGpPWpGaD
Suprofen—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	4.75e-05	0.000309	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.71e-05	0.000306	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.64e-05	0.000302	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.5e-05	0.000292	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	4.44e-05	0.000289	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.33e-05	0.000281	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—ALB—chronic obstructive pulmonary disease	4.31e-05	0.00028	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.14e-05	0.00027	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.12e-05	0.000268	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.1e-05	0.000267	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	4.06e-05	0.000264	CbGpPWpGaD
Suprofen—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	3.96e-05	0.000258	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.74e-05	0.000243	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	3.51e-05	0.000228	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.36e-05	0.000218	CbGpPWpGaD
Suprofen—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	3.33e-05	0.000217	CbGpPWpGaD
Suprofen—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	3.18e-05	0.000207	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.12e-05	0.000203	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.07e-05	0.0002	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.86e-05	0.000186	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	2.79e-05	0.000181	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.72e-05	0.000177	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.67e-05	0.000173	CbGpPWpGaD
Suprofen—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	2.11e-05	0.000137	CbGpPWpGaD
Suprofen—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	2.06e-05	0.000134	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	1.85e-05	0.00012	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.77e-05	0.000115	CbGpPWpGaD
Suprofen—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	1.59e-05	0.000103	CbGpPWpGaD
